Shareholders Equity: The sum of preferred and common equity items.
Intellia Therapeutics, Inc. (NTLA) had Shareholders Equity of $715.25M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$14.24M |
|
$-101.25M |
|
-- |
|
$14.24M |
|
$124.24M |
|
$-110.00M |
|
$8.74M |
|
$-101.25M |
|
$-101.25M |
|
$-101.25M |
|
$-101.25M |
|
$-101.25M |
|
$-101.25M |
|
$-110.00M |
|
$-107.52M |
|
103.73M |
|
103.73M |
|
$-0.98 |
|
$-0.98 |
|
| Balance Sheet Financials | |
$495.94M |
|
$22.81M |
|
$402.95M |
|
$898.89M |
|
$95.50M |
|
-- |
|
$88.14M |
|
$183.64M |
|
$715.26M |
|
$715.25M |
|
|
Shareholders Equity |
$715.25M |
105.33M |
|
| Cash Flow Statement Financials | |
$-248.55M |
|
$201.24M |
|
$14.65M |
|
$202.79M |
|
$170.12M |
|
$-32.66M |
|
$43.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-772.17% |
|
-772.17% |
|
-- |
|
-710.81% |
|
-710.81% |
|
$-249.53M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.25 |
|
71.73 |
|
-14.16% |
|
-14.16% |
|
-11.26% |
|
-14.16% |
|
$6.79 |
|
$-2.41 |
|
$-2.40 |
|